San Diego, June 22, 2026 (GLOBE NEWSWIRE) — FOR IMMEDIATE RELEASE
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Endure Biotherapeutics Receives NSF SBIR Phase I Grant for Phenylketonuria (PKU) Program and Reports Pig Study validates Engineered Native Bacteria platform technology
